LONDON and SALT LAKE CITY, Oct. 06, 2023 Renalytix plc , the first company to commercialize an FDA authorized artificial intelligence enabled blood test to assess risk of progressive kidney.
LONDON and SALT LAKE CITY, Sept. 25, 2023 Renalytix plc will report its fourth quarter and full year fiscal 2023 financial results on Thursday, September 28, 2023, before market open. The.
LONDON and SALT LAKE CITY, June 05, 2023 Renalytix plc will report its third quarter fiscal year 2023 financial results on Friday, June 9, 2023, before market open. The Company will host a. | June 5, 2023